See also this year's filing and all EDGAR filings for this company.
PDF Report 0001479290_2022_Revance_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001479290, Revance Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 246,117,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 202,298,000 |
| 2 | PropertyPlantAndEquipmentNet | 24,661,000 |
| 3 | remainder_Assets | 58,087,000 |
| 4 | LiabilitiesCurrent | 67,289,000 |
| 5 | LiabilitiesNoncurrent | 114,768,000 |
| 6 | remainder_Liabilities | 280,635,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 265,349,225 |
| 9 | ResearchAndDevelopmentExpense | 110,725,316 |
| 10 | remainder_Expenses | 45,791,799 |
| 11 | remainder_Revenues | 389,896,948 |
| 12 | remainder_NetIncome | -1,681,315 |
| 13 | remainder_ComprehensiveNetIncome | -13,778 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 531,163,000 |
| 1 | Liabilities | 462,692,000 |
| 2 | Expenses | 421,866,340 |
| 3 | Revenues | 389,896,948 |
| 4 | StockholdersEquity | 68,471,000 |
| 5 | NetIncome | -33,650,707 |
| 6 | ComprehensiveNetIncome | -33,657,596 |
| 7 | BaseVar | 903,656,690 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.233 |
| 9 | EconomicCapitalRatio | 1.64 |
Edgar->Model Mapping
Feature Distribution
Change over Time
